Evidence map›Paper›PMID 31144155›Full record

ReviewCurrent neurology and neuroscience reports2019

Neuroimaging Technological Advancements for Targeting in Functional Neurosurgery.

Alexandre Boutet, Robert Gramer, Christopher J Steele, Gavin J B Elias, Jürgen Germann, Ricardo Maciel, Walter Kucharczyk, Ludvic Zrinzo, Andres M Lozano, Alfonso Fasano

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current neurology and neuroscience reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Computational Neurosurgery in Deep Brain Stimulation.Advances in experimental medicine and biology · 2024
    Review
  6. Advances in Technical Aspects of Deep Brain Stimulation Surgery.Stereotactic and functional neurosurgery · 2023
    Review
  7. A Soft, High-Density Neuroelectronic Array.Npj flexible electronics · 2023
    Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alexandre BoutetJoint Department of Medical Imaging, University of Toronto, Toronto, ON, Canada.
Robert GramerUniversity Health Network, Toronto, ON, Canada.
Christopher J SteeleDepartment of Psychology, Concordia University, Montreal, Quebec, Canada.
Gavin J B EliasUniversity Health Network, Toronto, ON, Canada.
Jürgen GermannUniversity Health Network, Toronto, ON, Canada.
Ricardo MacielUniversity Health Network, Toronto, ON, Canada.
Walter KucharczykJoint Department of Medical Imaging, University of Toronto, Toronto, ON, Canada.
Ludvic ZrinzoFunctional Neurosurgery Unit, Department of Clinical and Movement Neurosciences, University College London, Queen Square Institute of Neurology, London, UK.
Andres M LozanoUniversity Health Network, Toronto, ON, Canada.
Alfonso FasanoUniversity Health Network, Toronto, ON, UK. alfonso.fasano@uhn.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewAblations and particularly deep brain stimulation (DBS) of a variety of CNS targets are established therapeutic tools for movement disorders. Accurate targeting of the intended structure is crucial for optimal clinical outcomes. However, most targets used in functional neurosurgery are sub-optimally visualized on routine MRI. This article reviews recent neuroimaging advancements for targeting in movement disorders. RECENT

findingsDedicated MRI sequences can often visualize to some degree anatomical structures commonly targeted during DBS surgery, including at 1.5-T field strengths. Due to recent technological advancements, MR images using ultra-high magnetic field strengths and new acquisition parameters allow for markedly improved visualization of common movement disorder targets. In addition, novel neuroimaging techniques have enabled group-level analysis of DBS patients and delineation of areas associated with clinical benefits. These areas might diverge from the conventionally targeted nuclei and may instead correspond to white matter tracts or hubs of functional networks. Neuroimaging advancements have enabled improved direct visualization-based targeting as well as optimization and adjustment of conventionally targeted structures.

Indexed as

Deep Brain StimulationHumansMagnetic Resonance ImagingMovement DisordersNeuroimagingNeurosurgeryNeurosurgical ProceduresDeep brain stimulationFunctional neurosurgeryMRINeuroimaging

Identifiers

PMID31144155

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.